Pirfenidone
Esbriet (pirfenidone) is a small molecule pharmaceutical. Pirfenidone was first approved as Esbriet on 2011-02-27. It is used to treat pulmonary fibrosis in the USA. It has been approved in Europe to treat idiopathic pulmonary fibrosis. Esbriet's patents are valid until 2037-03-28 (FDA).
| Trade Name | Esbriet |
|---|---|
| Common Name | Pirfenidone |
| Indication | idiopathic pulmonary fibrosis, pulmonary fibrosis |
| Drug Class |
